Parkinson’s Disease Research News

Newsfeed:

  • How gut bacteria affect the treatment of Parkinson’s disease
    (University of Groningen) Patients with Parkinson's disease are treated with levodopa, which is converted into dopamine, a neurotransmitter in the brain. In a study published on Jan. 18, in the journal Nature Communications, scientists from the University of Groningen show that gut bacteria can metabolize levodopa into dopamine. As dopamine ... read more
    Source: Eureka AlertPublished on 2019-01-18
  • Psychological Distress is a Risk Factor for Dementia
    A new study reports experiencing vital exhaustion, a symptom of psychological distress, during mid life may be associated with a higher risk of developing dementia later in life. ... read more
    Source: Neuro Science NewsPublished on 2019-01-17By Neuroscience News
  • How Manganese Produces a Parkinsonian Syndrome
    Study reports an accumulation of manganese in cells may disrupt protein transportation, resulting in Parkinsonian syndrome. ... read more
    Source: Neuro Science NewsPublished on 2019-01-16By Neuroscience News
  • Sea slug study illuminates how mitochondria move
    (Scripps Research Institute) Defects in the transport of cells' energy organelles are a suspected cause of diseases including Alzheimer's, ALS, Huntington's and Parkinson's. A new study reveals the genetics behind mitochondrial shifts. ... read more
    Source: Eureka AlertPublished on 2019-01-16
  • New Way By Which the Brain Marks Time Identified
    A new neuroimaging study helped researchers capture the processes by which the brain stores information related to when events happen. The findings could help further the understanding of age related dementia. ... read more
    Source: Neuro Science NewsPublished on 2019-01-15By Neuroscience News
  • Defective glial cells can push neurons toward Parkinson’s disease
    A team of scientists have discovered that astrocytes are linked to the buildup of a toxic protein that is one the hallmarks of Parkinson's disease. The work suggests an important role for glial cells in Parkinson's disease and offers potential new targets for developing therapies. ... read more
    Source: Science DailyPublished on 2019-01-15
  • Defective glial cells can push neurons toward Parkinson’s disease
    (IDIBELL-Bellvitge Biomedical Research Institute) A team of scientists from IDIBELL, the University of Barcelona and CMR[B] have discovered that astrocytes are linked to the buildup of a toxic protein that is one the hallmarks of Parkinson's disease. The work, which appeared January 10 in the journal Stem Cell Reports, suggests ... read more
    Source: Eureka AlertPublished on 2019-01-15
  • Herpes Virus and Tumors Evolved to Learn How to Manipulate the Same Ancient RNA
    A new study reports herpes virus utilizes ancient RNA to proliferate, mimicking the same process tumors have been found to manipulate. The findings could have implications for new treatment options and also may shed light on neurodegenerative diseases. ... read more
    Source: Neuro Science NewsPublished on 2019-01-14By Neuroscience News
  • Blood-Brain Barrier Breakdown an Early Driver of Dementia
    A new study reports leaky capillaries in the brain may be an early sign of Alzheimer's disease as it can signal cognitive impairment prior to the buildup of proteins associated with the neurodegenerative disease. ... read more
    Source: Neuro Science NewsPublished on 2019-01-14By Neuroscience News
  • FDA approves scalpel-free treatment for Parkinson’s disease tremor
    (University of Virginia Health System) The federal Food and Drug Administration has approved a new, scalpel-free treatment for tremor in patients with medication-resistant Parkinson's disease. ... read more
    Source: Eureka AlertPublished on 2019-01-14
  • Emergency and Urgent Hospitalizations Linked to Accelerated Cognitive Decline in Older Adults
    Researchers link urgent hospitalization to an increased rate of cognitive decline in older people not previously diagnosed with neurodegenerative diseases such as dementia or Alzheimer's disease. ... read more
    Source: Neuro Science NewsPublished on 2019-01-13By Neuroscience News
  • Gene therapy could eliminate drug side effect in Parkinson’s patients
    (Michigan State University) A Michigan State University researcher has received a $2.8 million federal grant to develop a gene therapy that could reduce and possibly eliminate a frustrating side effect of a drug commonly prescribed to Parkinson's patients. ... read more
    Source: Eureka AlertPublished on 2019-01-11
  • The road ahead: Parkinson’s research in 2019
      “In preparing for battle I have always found that plans are useless, but planning is indispensable” This quote has been attributed to General Dwight D. Eisenhower (Click here for the full story of this quote), and while the sentence does not immediately make a whole lot of sense, ... read more
    Source: The Science of Parkinson’s diseasePublished on 2019-01-10By Simon
  • Defective Glial Cells Can Push Neurons Toward Parkinson’s Disease
    A new study reveals a defective version of astrocytes may be linked to the build up of alpha synuclein and could spur Parkinson's disease. The findings show the important role glial cells play in Parkinson's and offers insights into new targets for therapies to fight the neurodegenerative disease. ... read more
    Source: Neuro Science NewsPublished on 2019-01-10By Neuroscience News
  • Exercise Hormone May Slow Alzheimer’s Progression
    Researchers report the brains of people with Alzheimer's disease contain less of the exercise related hormone called irisin. Boosting levels of irisin in the brain could slow the progression of the neurodegenerative disease. ... read more
    Source: Neuro Science NewsPublished on 2019-01-08By Neuroscience News
  • Histamines Can Boost Long Term Memory of Objects
    Researchers report histamines can help improve memory of objects up-to 25 days longer than normal in mice, as well as improving people's long term memory test scores. The study suggests taking histamines may help alleviate symptoms of memory disorders such as Alzheimer's and other dementias. ... read more
    Source: Neuro Science NewsPublished on 2019-01-08By Neuroscience News
  • The Number of People with Dementia Has Doubled in Sixteen Years
    A new study reports the number of people living with dementia globally more than doubled between 1990 and 2016. By 2050, more than 100 million people could be living with dementia related diseases, researchers report. The study suggests people could avoid the risk of developing dementia by maintaining a healthy ... read more
    Source: Neuro Science NewsPublished on 2019-01-06By Neuroscience News
  • 13 early signs of Parkinson’s disease
    People can sometimes miss the early signs and symptoms of Parkinson's disease, as they can be subtle and sporadic. In this article, we look at 13 signs of Parkinson's disease to look out for. ... read more
    Source: Medical News DailyPublished on 2019-01-03
  • Hyperactive Immune System Implicated in Aging Brain Disorders
    According to a new study, the immune system may play a critical role in damage associated with neurodegenerative disorders such as Alzheimer's disease and ALS. The study reports altering Cdk5 results in the death of dopamine neurons and slowed autophagy. ... read more
    Source: Neuro Science NewsPublished on 2019-01-02By Neuroscience News
  • New mouse model reminiscent of Leigh syndrome sheds light on mechanisms of neurodegeneration
    Researchers have identified a new role for PARL, a protein that has been linked to Parkinson's disease. They report that mice lacking PARL display specific problems in the nervous system reminiscent of Leigh syndrome instead. ... read more
    Source: Science DailyPublished on 2019-01-02
  • Innovative brain implant could improve Parkinson’s treatment
    A novel device able to both record and modulate electrical impulses in the brain may improve treatments for Parkinson's disease and related conditions. ... read more
    Source: Medical News DailyPublished on 2019-01-02
  • New mouse model reminiscent of Leigh syndrome sheds light on mechanisms of neurodegeneration
    (VIB (the Flanders Institute for Biotechnology)) Leuven researchers led by professor Bart De Strooper (VIB-KU Leuven) have identified a new role for PARL, a protein that has been linked to Parkinson's disease. In this week's edition of the Proceedings of the National Academy of Science, they report that mice lacking ... read more
    Source: Eureka AlertPublished on 2019-01-02
  • Exploration of umbelliferone based derivatives as potent MAO inhibitors
    (Bentham Science Publishers) Monoamine oxidase inhibitors are potential drug candidates within therapeutics of different neuropsychological and neurodegenerative disorders including anxiety, depression and Parkinson's disease. Our findings revealed a good correlation between experimental MAO inhibition and docking score by computational studies. Notably, the compounds with remarkable MAO inhibitory potential were also ... read more
    Source: Eureka AlertPublished on 2019-01-01
  • 2018: Year in review
      In this end-of-year post we review the year that was 2018. Month-by-month we will briefly discuss some of the major pieces of research/announcement that have define the year and advanced our understanding of Parkinson’s. The list is based on nothing more than the author’s personal opinion – ... read more
    Source: The Science of Parkinson’s diseasePublished on 2018-12-31By Simon
  • Wireless ‘pacemaker for the brain’ could offer new treatment for neurological disorders
    (University of California - Berkeley) A new neurostimulator developed by engineers at the University of California, Berkeley, can listen to and stimulate electric current in the brain at the same time, potentially delivering fine-tuned treatments to patients with diseases like epilepsy and Parkinson's. ... read more
    Source: Eureka AlertPublished on 2018-12-31
1 2 3 4 5 57